Statistics for Preclinical characterization of DUOC-01, a cell therapy product derived from banked umbilical cord blood for use as an adjuvant to umbilical cord blood transplantation for treatment of inherited metabolic diseases.
Total visits
| views | |
|---|---|
| Preclinical characterization of DUOC-01, a cell therapy product derived from banked umbilical cord blood for use as an adjuvant to umbilical cord blood transplantation for treatment of inherited metabolic diseases. | 34 |
Total visits per month
| views | |
|---|---|
| April 2024 | 0 |
| May 2024 | 1 |
| June 2024 | 0 |
| July 2024 | 1 |
| August 2024 | 0 |
| September 2024 | 1 |
| October 2024 | 0 |
File Visits
| views | |
|---|---|
| p292 Kurtzberg.pdf | 25 |